SQI Diagnostics Names Integrated Sciences as Australian Distributor | GenomeWeb

SQI Diagnostics said this week that Integrated Sciences will serve as the exclusive distributor for its in vitro diagnostic products in Australia.

Toronto-based SQI sells tests for rheumatoid arthritis and celiac disease. The assays are run on its SQiDWorks microarray platform. Both have been cleared for clinical use in Canada, the European Union, and the US.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.